We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More XAstraZeneca worked alongside the University of Oxford to develop its AZD1222 Covid-19 vaccine candidate (Credit: New Africa/Shutterstock)